All-systolic first-pass myocardial rest perfusion at a long saturation time using simultaneous multi-slice imaging and compressed sensing acceleration.
all-systolic myocardial rest perfusion
compressed sensing
dark rim artefact
perfusion contrast
simultaneous multi-slice
Journal
Magnetic resonance in medicine
ISSN: 1522-2594
Titre abrégé: Magn Reson Med
Pays: United States
ID NLM: 8505245
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
revised:
17
12
2020
received:
03
05
2020
accepted:
11
01
2021
pubmed:
23
3
2021
medline:
21
5
2021
entrez:
22
3
2021
Statut:
ppublish
Résumé
To enable all-systolic first-pass rest myocardial perfusion with long saturation times. To investigate the change in perfusion contrast and dark rim artefacts through simulations and surrogate measurements. Simulations were employed to investigate optimal saturation time for myocardium-perfusion defect contrast and blood-to-myocardium signal ratios. Two saturation recovery blocks with long/short saturation times (LTS/STS) were employed to image 3 slices at end-systole and diastole. Simultaneous multi-slice balanced steady state free precession imaging and compressed sensing acceleration were combined. The sequence was compared to a 3 slice-by-slice clinical protocol in 10 patients. Quantitative assessment of myocardium-peak pre contrast and blood-to-myocardium signal ratios, as well as qualitative assessment of perceived SNR, image quality, blurring, and dark rim artefacts, were performed. Simulations showed that with a bolus of 0.075 mmol/kg, a LTS of 240-470 ms led to a relative increase in myocardium-perfusion defect contrast of 34% ± 9%-28% ± 27% than a STS = 120 ms, while reducing blood-to-myocardium signal ratio by 18% ± 10%-32% ± 14% at peak myocardium. With a bolus of 0.05 mmol/kg, LTS was 320-570 ms with an increase in myocardium-perfusion defect contrast of 63% ± 13%-62% ± 29%. Across patients, LTS led to an average increase in myocardium-peak pre contrast of 59% (P < .001) at peak myocardium and a lower blood-to-myocardium signal ratio of 47% (P < .001) and 15% (P < .001) at peak blood/myocardium. LTS had improved motion robustness (P = .002), image quality (P < .001), and decreased dark rim artefacts (P = .008) than the clinical protocol. All-systolic rest perfusion can be achieved by combining simultaneous multi-slice and compressed sensing acceleration, enabling 3-slice cardiac coverage with reduced motion and dark rim artefacts. Numerical simulations indicate that myocardium-perfusion defect contrast increases at LTS.
Identifiants
pubmed: 33749026
doi: 10.1002/mrm.28712
pmc: PMC7611406
mid: EMS128764
doi:
Substances chimiques
Contrast Media
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
663-676Subventions
Organisme : British Heart Foundation
ID : PG/19/11/34243
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203148
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT 203148/Z/16/Z
Pays : United Kingdom
Informations de copyright
© 2021 The Authors. Magnetic Resonance in Medicine published by Wiley Periodicals LLC on behalf of International Society for Magnetic Resonance in Medicine.
Références
J Magn Reson Imaging. 2009 Feb;29(2):466-73
pubmed: 19161204
PLoS One. 2019 Feb 11;14(2):e0211738
pubmed: 30742641
J Magn Reson Imaging. 2001 Feb;13(2):313-7
pubmed: 11169840
J Cardiovasc Magn Reson. 2013 Oct 08;15:91
pubmed: 24103764
JACC Cardiovasc Imaging. 2013 May;6(5):600-9
pubmed: 23582358
Magn Reson Med. 2005 Apr;53(4):981-5
pubmed: 15799044
Magn Reson Med. 2005 Jul;54(1):129-37
pubmed: 15968648
Magn Reson Med. 2020 Nov;84(5):2429-2441
pubmed: 32306471
Magn Reson Med. 2010 Apr;63(4):858-64
pubmed: 20373386
Magn Reson Med. 2005 Oct;54(4):901-7
pubmed: 16142709
Magn Reson Med. 2020 Dec;84(6):3103-3116
pubmed: 32530064
J Cardiovasc Magn Reson. 2015 Aug 01;17:68
pubmed: 26231784
Magn Reson Med. 2019 Feb;81(2):1016-1030
pubmed: 30295955
Magn Reson Imaging. 2016 Nov;34(9):1329-1336
pubmed: 27502698
Magn Reson Med. 2007 Dec;58(6):1182-95
pubmed: 17969013
J Cardiovasc Magn Reson. 2018 Dec 10;20(1):84
pubmed: 30526627
Magn Reson Med. 2009 Aug;62(2):373-83
pubmed: 19353669
Magn Reson Med. 2013 Oct;70(4):1082-6
pubmed: 23172845
J Cardiovasc Magn Reson. 2017 Apr 7;19(1):43
pubmed: 28385161
Magn Reson Med. 1989 May;10(2):246-55
pubmed: 2761383
Magn Reson Med. 2014 Jul;72(1):124-36
pubmed: 24030840
Radiology. 2005 May;235(2):423-30
pubmed: 15858084
Magn Reson Med. 2019 Feb;81(2):852-862
pubmed: 30311689
J Magn Reson Imaging. 2014 Jun;39(6):1575-87
pubmed: 24151153
Magn Reson Med. 2009 Mar;61(3):734-8
pubmed: 19097242
J Cardiovasc Magn Reson. 2018 Nov 19;20(1):74
pubmed: 30454074
IEEE Trans Med Imaging. 2015 Jan;34(1):72-85
pubmed: 25095251
Magn Reson Med. 2015 Dec;74(6):1661-74
pubmed: 26052843
Magn Reson Med. 2019 Jan;81(1):129-139
pubmed: 30058197
Magn Reson Med. 2005 Mar;53(3):684-91
pubmed: 15723404
J Am Coll Cardiol. 2012 Dec 18;60(24):e44-e164
pubmed: 23182125
Circ Cardiovasc Imaging. 2008 Sep;1(2):122-30
pubmed: 19808529
J Cardiovasc Magn Reson. 2014 Feb 24;16:19
pubmed: 24565078
Circ Cardiovasc Imaging. 2013 Mar 1;6(2):339-48
pubmed: 23512780
Magn Reson Med. 2011 Jan;65(1):157-64
pubmed: 20872868
Magn Reson Med. 2005 Nov;54(5):1295-9
pubmed: 16200553
Magn Reson Med. 2020 Jun;83(6):2185-2196
pubmed: 31746055
Phys Med. 2019 Aug;64:157-165
pubmed: 31515014
Magn Reson Med. 2014 Sep;72(3):689-98
pubmed: 24123153
Invest Radiol. 2006 Mar;41(3):213-21
pubmed: 16481903
Radiology. 2014 Sep;272(3):683-9
pubmed: 24702727